Intervet Inc.
242Patents
239Active
242Granted
60Portfolio score
Filing activity: Jul 9, 1980 → Nov 13, 2023 · 33 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11071279B2 | Method and system for tracking health in animal populations | Human Necessities | 23 | Active |
| US8034845B2 | Compositions and method for treating infection in cattle and swine | Human Necessities | 19 | Active |
| US8044102B2 | Compositions and method for treating infection in cattle and swine | Human Necessities | 16 | Active |
| US4303062A | Therapeutic magnet | Human Necessities | 15 | Expired |
| US9173870B2 | Topical localized isoxazoline formulation | Human Necessities | 13 | Active |
| US10863727B2 | Method for automatic sea lice monitoring in salmon aquaculture | Emerging Cross-Sectional Technologies | 11 | Active |
| US9532978B2 | Topical localized isoxazoline formulation | Human Necessities | 11 | Active |
| US9393298B2 | Liquid stable bovine virus vaccines | Chemistry; Metallurgy | 7 | Active |
| US9345686B2 | Macrocyclic lactone drug delivery system | Human Necessities | 7 | Active |
| US9095516B2 | Process to form an orally disintegrating tablet for human use | Human Necessities | 7 | Active |
| US7732187B2 | Recombinant attenuated clostridium organisms and vaccine | Human Necessities | 6 | Active |
| US9532946B2 | Manufacturing of semi-plastic pharmaceutical dosage units | Performing Operations; Transporting | 5 | Active |
| US7713950B2 | Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US9314519B2 | Liquid stable virus vaccines | Chemistry; Metallurgy | 5 | Active |
| US7786329B2 | Process for preparing ester oxazolidine compounds and their conversion to Florfenicol | Chemistry; Metallurgy | 5 | Active |
| US9839613B2 | Dry formulations of vaccines that are room temperature stable | Chemistry; Metallurgy | 5 | Active |
| US8076456B2 | Fusion proteins comprising canine thymic stromal lymphopoietin protein and uses thereof | Physics | 5 | Active |
| US10372967B1 | Automated parasite analysis system | Physics | 5 | Active |
| US8932604B2 | Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens | Chemistry; Metallurgy | 5 | Active |
| US8784829B2 | Lawsonia intracellularis vaccines | Human Necessities | 4 | Active |
| US8546149B2 | Potency test for vaccine formulations | Physics | 4 | Active |
| US8791242B2 | Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms | Physics | 4 | Active |
| US8560349B2 | Method of documenting animal treatment | Physics | 4 | Active |
| US9050281B2 | Coccidiosis vaccines | Human Necessities | 4 | Active |
| US9944704B2 | Antibodies against canine PD-1 | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.